KingstronBio's Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement
CompanyMedical Device

KingstronBio’s Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement

iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
CompanyDeals

iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology

Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs
Company

Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs

Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment
CompanyDrug

Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment

Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies
CompanyDeals

Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies

Bayer's Vitrakvi Fully Approved by FDA for NTRK Fusion Solid Tumors
CompanyDrug

Bayer’s Vitrakvi Fully Approved by FDA for NTRK Fusion Solid Tumors

Luye Pharma Launches Rotigotine Luye in UK for Parkinson's and Restless Leg Syndrome
CompanyDrug

Luye Pharma Launches Rotigotine Luye in UK for Parkinson’s and Restless Leg Syndrome

Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization
CompanyDeals

Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization

CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine
CompanyDrug

CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine

Kangtai Biological's Pentavalent Rotavirus Vaccine Enters Phase III Trials
CompanyDrug

Kangtai Biological’s Pentavalent Rotavirus Vaccine Enters Phase III Trials

Zelgen Biopharma's ZG005 Approved for Gastrointestinal Tumor Trials in China
CompanyDrug

Zelgen Biopharma’s ZG005 Approved for Gastrointestinal Tumor Trials in China

HemaCell's XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome
CompanyDrug

HemaCell’s XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome